Clariant Future Growth
Future criteria checks 3/6
Clariant is forecast to grow earnings and revenue by 49.4% and 2.1% per annum respectively. EPS is expected to grow by 50.6% per annum. Return on equity is forecast to be 12.9% in 3 years.
Key information
49.4%
Earnings growth rate
50.58%
EPS growth rate
| Chemicals earnings growth | 8.3% |
| Revenue growth rate | 2.1% |
| Future return on equity | 12.86% |
| Analyst coverage | Good |
| Last updated | 23 Apr 2026 |
Recent future growth updates
Recent updates
Narrative Update • May 02
CLN: Trimmed Assumptions And Downgrades Will Shape Measured Forward Expectations
Analysts have trimmed their price target on Clariant by CHF 0.09 to reflect updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, in line with recent research that includes a downgrade from some firms. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as more realistic.
Narrative Update • Apr 17
CLN: Earnings Quality And Steadier Cash Generation Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 12.37 from CHF 12.77, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E following recent research, including a downgrade from Goldman Sachs. Analyst Commentary While the latest research includes a downgrade from Goldman Sachs, some views across the Street remain constructive, focusing on how Clariant could still convert its fundamentals into long term value creation.Narrative Update • Apr 03
CLN: Recent Downgrade And Trimmed Assumptions Will Shape Potential Upside
Analysts have trimmed their CHF price targets for Clariant by a small amount, reflecting more cautious assumptions on revenue growth and profit margins. They are still applying a slightly higher future P/E multiple in their updated models.
Narrative Update • Mar 20
CLN: Lower CHF 7.80 Outlook Will Restrain Upside As Legal Claims Persist
Analysts have trimmed their average price target on Clariant to CHF 7.80 from CHF 8.00, reflecting slightly softer expectations that align with recent downgrades and more cautious assumptions on growth and returns. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the latest moves reflecting concerns around execution, growth visibility and how the current share price lines up with those risks.Narrative Update • Mar 05
CLN: Legal Claims And Recent Downgrade Will Frame Potential Upside Ahead
Analysts have trimmed their price expectations for Clariant, with the average target moving modestly lower to around CHF 7.80. This reflects updated assumptions on fair value, discount rates and future P/E in light of recent research calls.Narrative Update • Feb 19
CLN: Legal Claims And Rating Downgrade Will Shape Measured Future Upside Potential
The updated analyst price target for Clariant now stands at CHF 8.80, a small change from the prior CHF 8.74, as analysts factor in recent target cuts around CHF 7.80 and adjust their assumptions on discount rates, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts see the updated CHF 8.80 target as reflecting a more refined view of discount rates and earnings power, rather than a fundamental shift in the story.Narrative Update • Feb 05
CLN: Lower CHF 7.80 Outlook Will Cap Upside As Legal Claims Linger
Analysts have reduced their price target on Clariant to CHF 7.80 from CHF 8.00 to reflect updated views on the company’s discount rate, revenue growth assumptions, profit margins and future P/E. Analyst Commentary Bearish analysts are signaling a more cautious stance on Clariant by aligning their valuation work with a CHF 7.80 price level.Narrative Update • Jan 22
CLN: Revised Expectations And Legal Claims Will Shape Future Upside Potential
Analysts have reduced their price target for Clariant to CHF 7.80 from CHF 8.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent research points to a more cautious stance on Clariant, with the price target trimmed to CHF 7.80 from CHF 8 and the rating held steady at Hold.Narrative Update • Jan 07
CLN: Legal Claims And Steady Earnings Outlook Will Support Bullish Re Rating
Analysts have trimmed their price target on Clariant to CHF 7.80, reflecting updated assumptions for fair value, revenue growth, margins and future P/E multiples following recent research. Analyst Commentary Recent research points to a more measured stance on Clariant, with the revised CHF 7.80 target reflecting updated views on valuation, earnings power and the multiples investors might be willing to pay for the shares.Narrative Update • Dec 21
CLN: Reduced Price Outlook Will Limit Upside Amid Rising Legal Risks
Analysts have reduced their price target on Clariant by CHF 1.50 to CHF 8.10, reflecting more cautious assumptions on revenue growth and valuation multiples, even though margin expectations have improved slightly. Analyst Commentary Bearish analysts have framed the lower price target as a reflection of rising skepticism around Clariant's ability to deliver on its medium term growth ambitions, despite recent progress on margins.Narrative Update • Dec 07
CLN: Margin Recovery And Legal Overhang Will Shape Future Share Resilience
Analysts have trimmed their price target on Clariant by CHF 1.50 to reflect a slightly lower assumed future price to earnings multiple and discount rate, even as forecasts for profit margins have improved. Analyst Commentary Analysts remain balanced in their view on Clariant, with modest adjustments to valuation assumptions reflecting both improving profitability and lingering execution risks.Narrative Update • Nov 23
CLN: Market Recovery And Margin Discipline Will Drive Future Share Resilience
Clariant's analyst price target has been revised downward from CHF 9.78 to CHF 9.51. Analysts cite tempered expectations for near-term performance amid evolving market conditions.Narrative Update • Nov 07
CLN: Margin Improvements And Efficiency Efforts Will Offset Market Headwinds
Analysts have reduced their price target for Clariant from CHF 9.60 to CHF 8.10. This adjustment reflects lowered growth expectations and a more cautious outlook on the company's future performance.Analysis Article • Nov 04
Cautious Investors Not Rewarding Clariant AG's (VTX:CLN) Performance Completely
There wouldn't be many who think Clariant AG's ( VTX:CLN ) price-to-earnings (or "P/E") ratio of 20.4x is worth a...Narrative Update • Oct 24
Earnings Recovery Will Depend On Stabilization And Cost Improvements Amid Headwinds
Narrative Update: Clariant Analyst Price Target Adjustment Clariant’s analyst price target has been reduced significantly, dropping from CHF 9.60 to CHF 8.10. Analysts cite softer revenue growth and profit margin expectations in their revised outlook.Narrative Update • Oct 10
China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
Narrative Update on Clariant Clariant's analyst price target has been revised downward from CHF 10.95 to CHF 10.58. Analysts cite a combination of cautious revenue growth assumptions and a recent reduction in price targets by major banks.Narrative Update • Sep 26
China Expansion And Sustainable Solutions Will Boost Long-Term Appeal
The minor decrease in Clariant's price target reflects a combination of lower revenue growth expectations and a modestly higher discount rate, resulting in a slight fair value reduction to CHF10.95. What's in the News Clariant AG dropped from the FTSE All-World Index (USD).Analysis Article • Sep 17
Is Clariant AG (VTX:CLN) Trading At A 32% Discount?
Key Insights Clariant's estimated fair value is CHF11.89 based on 2 Stage Free Cash Flow to Equity Current share price...Analysis Article • Aug 26
We Think Clariant (VTX:CLN) Is Taking Some Risk With Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Aug 08
Clariant's (VTX:CLN) Anemic Earnings Might Be Worse Than You Think
SWX:CLN 1 Year Share Price vs Fair Value Explore Clariant's Fair Values from the Community and select yours Clariant...Analysis Article • May 30
Clariant (VTX:CLN) Has Affirmed Its Dividend Of CHF0.42
Clariant AG ( VTX:CLN ) has announced that it will pay a dividend of CHF0.42 per share on the 4th of June. Based on...Analysis Article • May 05
These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Extensively
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Apr 13
Are Investors Undervaluing Clariant AG (VTX:CLN) By 39%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Clariant fair value estimate is CHF13.37 Current share price...Analysis Article • Mar 26
Clariant AG's (VTX:CLN) CEO Might Not Expect Shareholders To Be So Generous This Year
Key Insights Clariant's Annual General Meeting to take place on 1st of April Salary of CHF1.20m is part of CEO Conrad...Analysis Article • Mar 05
Clariant AG Just Missed EPS By 6.0%: Here's What Analysts Think Will Happen Next
It's been a sad week for Clariant AG ( VTX:CLN ), who've watched their investment drop 10% to CHF9.76 in the week since...Analysis Article • Mar 02
Take Care Before Diving Into The Deep End On Clariant AG (VTX:CLN)
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") above 21x, you may consider...
New Narrative • Dec 18
Restructuring, Lucas Meyer Cosmetics, And Sunliquid Set To Boost Margins And Drive Earnings
Identifying restructuring opportunities and targeting significant savings could improve Clariant's net margins and earnings efficiency in the coming years.Analysis Article • Nov 27
Estimating The Intrinsic Value Of Clariant AG (VTX:CLN)
Key Insights The projected fair value for Clariant is CHF10.85 based on 2 Stage Free Cash Flow to Equity Clariant's...Analysis Article • Nov 09
It's A Story Of Risk Vs Reward With Clariant AG (VTX:CLN)
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...Analysis Article • Aug 07
Clariant's (VTX:CLN) Solid Earnings Have Been Accounted For Conservatively
The stock was sluggish on the back of Clariant AG's ( VTX:CLN ) recent earnings report. Our analysis suggests that...Analysis Article • Jul 17
Why Investors Shouldn't Be Surprised By Clariant AG's (VTX:CLN) Low P/S
Clariant AG's ( VTX:CLN ) price-to-sales (or "P/S") ratio of 1.1x might make it look like a strong buy right now...Analysis Article • Apr 23
What Is Clariant AG's (VTX:CLN) Share Price Doing?
Clariant AG ( VTX:CLN ), might not be a large cap stock, but it received a lot of attention from a substantial price...Analysis Article • Apr 03
Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now
Key Insights Clariant to hold its Annual General Meeting on 9th of April Total pay for CEO Conrad Keijzer includes...Analysis Article • Nov 22
An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued
Key Insights The projected fair value for Clariant is CHF25.95 based on 2 Stage Free Cash Flow to Equity Current share...Analysis Article • Oct 31
Clariant (VTX:CLN) Takes On Some Risk With Its Use Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Jul 30
Clariant (VTX:CLN) Seems To Use Debt Quite Sensibly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 4,076 | 260 | 373 | 593 | 9 |
| 12/31/2027 | 3,983 | 261 | 356 | 579 | 15 |
| 12/31/2026 | 3,844 | 215 | 322 | 574 | 14 |
| 12/31/2025 | 3,915 | -75 | 273 | 419 | N/A |
| 9/30/2025 | 3,989 | 19 | 250 | 421 | N/A |
| 6/30/2025 | 4,063 | 113 | 226 | 422 | N/A |
| 3/31/2025 | 4,108 | 179 | 218 | 420 | N/A |
| 12/31/2024 | 4,152 | 244 | 210 | 418 | N/A |
| 6/30/2024 | 4,163 | 118 | 251 | 455 | N/A |
| 3/31/2024 | 4,270 | 143 | 233 | 438 | N/A |
| 12/31/2023 | 4,377 | 168 | 215 | 421 | N/A |
| 6/30/2023 | 4,919 | -98 | 400 | 597 | N/A |
| 3/31/2023 | 5,059 | -115 | 346 | 550 | N/A |
| 12/31/2022 | 5,198 | -133 | 291 | 502 | N/A |
| 9/30/2022 | 5,050 | 107 | 153 | 417 | N/A |
| 6/30/2022 | 4,901 | 346 | 15 | 331 | N/A |
| 3/31/2022 | 4,637 | 305 | 9 | 347 | N/A |
| 12/31/2021 | 4,372 | 263 | 3 | 363 | N/A |
| 9/30/2021 | 4,161 | 199 | -16 | 329 | N/A |
| 6/30/2021 | 3,949 | 135 | -35 | 295 | N/A |
| 3/31/2021 | 3,905 | 121 | 18 | 332 | N/A |
| 12/31/2020 | 3,860 | 106 | 71 | 369 | N/A |
| 6/30/2020 | 4,115 | 141 | 192 | 485 | N/A |
| 3/31/2020 | 4,257 | 40 | 207 | 497 | N/A |
| 12/31/2019 | 4,399 | -62 | 221 | 509 | N/A |
| 6/30/2019 | 4,409 | -67 | N/A | 541 | N/A |
| 3/31/2019 | 4,407 | 64 | N/A | 536 | N/A |
| 12/31/2018 | 4,404 | 194 | N/A | 530 | N/A |
| 9/30/2018 | 4,937 | 223 | N/A | N/A | N/A |
| 6/30/2018 | 5,469 | 251 | N/A | 414 | N/A |
| 3/31/2018 | 5,923 | 264 | N/A | 421 | N/A |
| 12/31/2017 | 6,377 | 277 | N/A | 428 | N/A |
| 9/30/2017 | 6,229 | 276 | N/A | 491 | N/A |
| 6/30/2017 | 6,080 | 274 | N/A | 554 | N/A |
| 3/31/2017 | 5,964 | 264 | N/A | 600 | N/A |
| 12/31/2016 | 5,847 | 253 | N/A | 646 | N/A |
| 9/30/2016 | 5,899 | 211 | N/A | 733 | N/A |
| 6/30/2016 | 5,835 | 203 | N/A | 645 | N/A |
| 3/31/2016 | 5,792 | 195 | N/A | 592 | N/A |
| 12/31/2015 | 5,807 | 217 | N/A | 502 | N/A |
| 9/30/2015 | 5,867 | 275 | N/A | 517 | N/A |
| 6/30/2015 | 5,964 | 272 | N/A | 512 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.6%).
Earnings vs Market: CLN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CLN is expected to become profitable in the next 3 years.
Revenue vs Market: CLN's revenue (2.1% per year) is forecast to grow slower than the Swiss market (4.8% per year).
High Growth Revenue: CLN's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLN's Return on Equity is forecast to be low in 3 years time (12.9%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/08 11:27 |
| End of Day Share Price | 2026/05/08 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Clariant AG is covered by 35 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Katie Richards | Barclays |